IAMA Therapeutics, a start-up company that will develop a new drug candidate for neurodevelopmental dysfunctions such as autism spectrum disorders, is underway. It stems from the work of two research

The DISCOver project was born at the G. Gaslini Institute in Genoa and aims to study the genetic basis of cortical developmental defects, to explore innovative approaches to personalized medicine.

Through an international collaboration, led by Prof. Ingrid E. Scheffer of the University of Melbourne – Australia, the phenotypes and genotypes of 87 patients with NEXMIF encephalopathy were analyzed. Phenotypic

Prof. Heng-Ye Man, head of the Department of Biology at Boston University – Massachusetts USA, and his research group have been studying the correlation between the NEXMIF / KIDLIA gene